Receptor component protein, an endogenous allosteric modulator of family B G protein coupled receptors
Receptor component protein, an endogenous allosteric modulator of family B G protein coupled receptors
复制标题
受体成分蛋白,B 族 G 蛋白偶联受体的内源变构调节剂
DOI:
10.1016/j.bbamem.2019.183174
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
D. Poyner
中科院分区:
文献类型:
--
作者:
S. Routledge;J. Simms;A. Clark;Ho Yan Yeung;M. Wigglesworth;I. Dickerson;P. Kitchen;G. Ladds;D. Poyner
Receptor component protein (RCP) is a 148 amino acid intracellular peripheral membrane protein, previously identified as promoting the coupling of CGRP to cAMP production at the CGRP receptor, a heterodimer of calcitonin receptor like-receptor (CLR), a family B G protein-coupled receptor (GPCR) and receptor activity modifying protein 1 (RAMP1). We extend these observations to show that it selectively enhances CGRP receptor coupling to Gs but not Gq or pERK activation. At other family B GPCRs, it enhances cAMP production at the calcitonin, corticotrophin releasing factor type 1a and glucagon-like peptide type 2 receptors with their cognate ligands but not at the adrenomedullin type 1 (AM1), gastric inhibitory peptide and glucagon-like peptide type 1 receptors, all expressed in transfected HEK293S cells. However, there is also cell-line variability as RCP did not enhance cAMP production at the endogenous calcitonin receptor in HEK293T cells and it has previously been reported that it is active on the AM1receptor expressed on NIH3T3 cells. RCP appears to behave as a positive allosteric modulator at coupling a number of family B GPCRs to Gs, albeit in a manner that is regulated by cell-specific factors. It may exert its effects at the interface between the 2nd intracellular loop of the GPCR and Gs, although there is likely to be some overlap between this location and that occupied by the C-terminus of RAMPs if they bind to the GPCRs.
登录
查看更多内容
影响因子:
4.1
作者:
S. Routledge;G. Ladds;D. Poyner
通讯作者:
S. Routledge;G. Ladds;D. Poyner
影响因子:
3.9
作者:
M. A. Prado;B. Evans-Bain;I. Dickerson
通讯作者:
M. A. Prado;B. Evans-Bain;I. Dickerson
DOI:
10.1146/annurev-pharmtox-010715-103120
发表时间:
2016
影响因子:
12.5
作者:
Hay DL;Pioszak AA
通讯作者:
Pioszak AA
影响因子:
2.8
作者:
Dickerson IM
通讯作者:
Dickerson IM